Cagrilintide is a long-acting amylin analogue frequently studied for its role in metabolic health and appetite regulation. As a non-selective amylin receptor agonist, it represents a significant area of research in weight management and glucose homeostasis.

Peptide Classification and Description

Cagrilintide is a synthetic long-acting analogue of amylin, a naturally occurring peptide co-released with insulin by pancreatic beta cells. It is primarily utilized in laboratory settings for amylin receptor agonist research and exploratory metabolic studies.

Targets, Effects, and Explored Roles

Category	Cagrilintide Research Details
Primary Targets	Amylin receptors ($AMY_{1}$, $AMY_{2}$, and $AMY_{3}$) and calcitonin receptors.
Potential Effects	Delays gastric emptying, suppresses glucagon secretion, and increases satiety signaling.
Explored Roles	Studies focus on its impact on liver function, cardiovascular systems, and synergistic effects when combined with GLP-1 agonists.

Core Mechanism and Function

Peptide	Mechanism of Action	Key Biological Function
Cagrilintide	Acts as a potent amylin receptor agonist to modulate central energy balance.	Promotes weight reduction by decreasing energy intake and enhancing metabolic pathway efficiency.

Clinical Potential

While currently designated for research, Cagrilintide holds significant interest in several clinical investigational areas:

Obesity Management: Investigating its ability to achieve sustainable weight loss through central appetite suppression.
Metabolic Syndrome: Exploring its role in improving glucose control and reducing lipid accumulation.
Combination Therapies: Researching the "CagriSema" model, which combines Cagrilintide with Semaglutide for enhanced metabolic outcomes.

Strictly RUO: This product is for Research Use Only. No clinical, diagnostic, or veterinary use is permitted.

Customer Reviews

Average Ratings

Write a review